Literature DB >> 27280421

Laboratory Diagnosis of Infections in Cancer Patients: Challenges and Opportunities.

N Esther Babady1.   

Abstract

Infections remain a significant cause of morbidity and mortality in cancer patients. The differential diagnosis for these patients is often wide, and the timely selection of the right clinical tests can have a significant impact on their survival. However, laboratory findings with current methodologies are often negative, challenging clinicians and laboratorians to continue the search for the responsible pathogen. Novel methodologies are providing increased sensitivity and rapid turnaround time to results but also challenging our interpretation of what is a clinically significant pathogen in cancer patients. This minireview provides an overview of the most common infections in cancer patients and discusses some of the challenges and opportunities for the clinical microbiologist supporting the care of cancer patients.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27280421      PMCID: PMC5078537          DOI: 10.1128/JCM.00604-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  80 in total

1.  HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.

Authors:  Danielle M Zerr; Michael Boeckh; Colleen Delaney; Paul J Martin; Hu Xie; Amanda L Adler; Meei-Li Huang; Lawrence Corey; Wendy M Leisenring
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-26       Impact factor: 5.742

Review 2.  Colonization versus carriage of Clostridium difficile.

Authors:  Curtis J Donskey; Sirisha Kundrapu; Abhishek Deshpande
Journal:  Infect Dis Clin North Am       Date:  2015-01-13       Impact factor: 5.982

3.  Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation.

Authors:  Stefan Schwartz; Maria Vergoulidou; Eckart Schreier; Christoph Loddenkemper; Mark Reinwald; Martin Schmidt-Hieber; Willy A Flegel; Eckhard Thiel; Thomas Schneider
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

4.  Rapidly growing mycobacteria infection in patients with cancer.

Authors:  Gil Redelman-Sidi; Kent A Sepkowitz
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

5.  Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.

Authors:  Enrico M Trecarichi; Mario Tumbarello; Teresa Spanu; Morena Caira; Luana Fianchi; Patrizia Chiusolo; Giovanni Fadda; Giuseppe Leone; Roberto Cauda; Livio Pagano
Journal:  J Infect       Date:  2009-03-09       Impact factor: 6.072

6.  Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Jun Aoki; Ayumi Numata; Eri Yamamoto; Eriko Fujii; Masatsugu Tanaka; Heiwa Kanamori
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-27       Impact factor: 5.742

7.  A history of cancer chemotherapy.

Authors:  Vincent T DeVita; Edward Chu
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

8.  Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients.

Authors:  Filippo Milano; Angela P Campbell; Katherine A Guthrie; Jane Kuypers; Janet A Englund; Lawrence Corey; Michael Boeckh
Journal:  Blood       Date:  2009-12-30       Impact factor: 22.113

9.  Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.

Authors:  R Y Hachem; D P Kontoyiannis; R F Chemaly; Y Jiang; R Reitzel; I Raad
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

Review 10.  Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.

Authors:  P Lewis White; John R Wingard; Stéphane Bretagne; Jürgen Löffler; Thomas F Patterson; Monica A Slavin; Rosemary A Barnes; Peter G Pappas; J Peter Donnelly
Journal:  Clin Infect Dis       Date:  2015-06-25       Impact factor: 9.079

View more
  5 in total

1.  Detection of gastrointestinal pathogens in oncology patients by highly multiplexed molecular panels.

Authors:  C C Otto; L H Chen; T He; Y-W Tang; N E Babady
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-20       Impact factor: 3.267

2.  Pattern of Antimicrobial Sensitivity in Microbiologically Documented Infections in Neutropenic Patients with Haematological Malignancies: A single Center Study.

Authors:  Aisha Jamal; Naveena Fatima; Sajjad Shaikh; Bushra Kaleem; Qurratul Ain Rizvi; Uzma Zaidi; Munira Borhany; Tahir Shamsi
Journal:  Indian J Microbiol       Date:  2019-03-04       Impact factor: 2.461

3.  Sepsis in patients with haematological versus solid cancer: a retrospective cohort study.

Authors:  Ralphe Bou Chebl; Rawan Safa; Mohammad Sabra; Ali Chami; Iskandar Berbari; Sarah Jamali; Maha Makki; Hani Tamim; Gilbert Abou Dagher
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

4.  Performance of the sōna Aspergillus Galactomannan Lateral Flow Assay in a Cancer Patient Population.

Authors:  Krupa Jani; Tracy McMillen; Sejal Morjaria; N Esther Babady
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

5.  Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infection.

Authors:  Maria Reckziegel; Claudia Weber-Osel; Roland Zell; Andi Krumbholz; Renate Egerer; Bernd Gruhn; Florian Kubek; Mario Walther; Stefanie Wilhelm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-05-27       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.